Targeting the SUMO pathway primes all-trans retinoic acid-induced differentiation of non-promyelocytic acute myeloid leukemias.
Baik, H., Hossein, S-M., Kowalczyk, J., Boulanger, M., Zaghdoudi, S., Salem, T., Sarry, J-E., Hicheri, Y., Cartron, G., Piechaczyk, M(*). and Bossis, G.(*).
2018
Cancer Res
/ vol Feb 27
10.1158/0008-5472.CAN-17-3361.
IGMM team(s) involved in this publication
